As per the research report, the size of the Europe Contrast Injector Market is valued at USD 131.03 million in 2020 and is projected to be growing at a CAGR of 7.5%, to touch USD 188.11 million by 2025 during the forecast period 2020-2025.
The main function of a Contrast Injector is to inject contrast media into the bloodstream. Present-day injectors offer substantial benefits such as the integration of IT and the utility of the computer-controlled system which deliver total control over the injection parameters.
Contrast Injectors also knew as pressure/power injectors are extensively used in the fields of magnetic resonance imaging (MRI), computed tomography and interventional radiology. Contrast Injectors have the ability to deliver exact amounts of contrast agents at desirable flow rates which aid substantially in medical imaging procedures.
The growth of the Europe Contrast Injector Market is mainly driven by the increasing approvals for contrast media use, supported by the rapid inclusion of IT in this sector. IT integration has been welcomed in developed economies of Europe, as its integration rids the risk of human error almost completely. Other driving factors include the cost savings offered by automated injectors and the increasing number of public and private diagnostic centers. However, side reactions and side effects related to the use of contrast media are expected to be the factors limiting market growth, to a certain extent.
This research report segmented and sub-segmented into the following categories:
Europe holds the second position in terms of market share globally. There is potential for market growth due to the presence of some untapped markets coupled with the rising approvals for the use of contrast media. The development of IT integrated and automated contrast injectors is expected to enrich market growth in the region.
Key players operating in the Europe Contrast Injector Market profiled in this report are Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Injector Systems
5.1.2.1 CT Injector Systems
5.1.2.2 MRI Injector Systems
5.1.2.3 Angiography Injector Systems
5.1.3 Consumables
5.1.3.1 Injector Heads
5.1.3.2 Syringes
5.1.3.3 Tubing
5.1.3.4 Other Consumables
5.1.4 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Radiology
5.2.3 Interventional Cardiology
5.2.4 Interventional Radiology
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Bracco Imaging S.p.A.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bayer HealthCare
8.3 Guerbet Group
8.4 Medtron AG
8.5 ulrich GmbH & Co. KG
8.6 GE Healthcare
8.7 AngioDynamics
8.8 Nemoto Kyorindo Co.
8.9 Sino Medical- Device Technology
8.10 VIVID IMAGING
8.11 Apollo RT Co.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Feb 2020
